MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 31 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $4,000 | 0.0% | 47 | 0.0% | 0.00% | – |
| Q3 2019 | $4,000 | +33.3% | 47 | +74.1% | 0.00% | – |
| Q2 2019 | $3,000 | -89.3% | 27 | -88.1% | 0.00% | – |
| Q1 2019 | $28,000 | +12.0% | 227 | 0.0% | 0.00% | – |
| Q4 2018 | $25,000 | -47.9% | 227 | 0.0% | 0.00% | – |
| Q3 2018 | $48,000 | -45.5% | 227 | -69.8% | 0.00% | -100.0% |
| Q2 2018 | $88,000 | 0.0% | 752 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $88,000 | +1660.0% | 752 | +1346.2% | 0.00% | – |
| Q4 2017 | $5,000 | +150.0% | 52 | 0.0% | 0.00% | – |
| Q3 2017 | $2,000 | +100.0% | 52 | 0.0% | 0.00% | – |
| Q2 2017 | $1,000 | 0.0% | 52 | 0.0% | 0.00% | – |
| Q1 2017 | $1,000 | 0.0% | 52 | -35.0% | 0.00% | – |
| Q4 2016 | $1,000 | 0.0% | 80 | 0.0% | 0.00% | – |
| Q3 2016 | $1,000 | – | 80 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthCor Management, L.P. | 1,402,250 | $93,614,000 | 4.00% |
| Parkman Healthcare Partners LLC | 30,000 | $2,003,000 | 0.93% |
| ARMISTICE CAPITAL, LLC | 216,000 | $14,420,000 | 0.89% |
| Avoro Capital Advisors LLC | 349,000 | $23,299,000 | 0.79% |
| Rock Springs Capital Management LP | 250,000 | $16,690,000 | 0.69% |
| Capital Impact Advisors, LLC | 24,351 | $1,626,000 | 0.68% |
| Baker Brothers Advisors | 1,499,212 | $100,087,000 | 0.62% |
| EWG Elevate Inc. | 11,086 | $740,000 | 0.56% |
| SHIKIAR ASSET MANAGEMENT INC | 12,000 | $801,000 | 0.54% |
| DAFNA Capital Management LLC | 13,600 | $908,000 | 0.38% |